Linezolid-associated toxic optic neuropathy

J. C. Rucker, S. R. Hamilton, D. Bardenstein, C. M. Isada, M. S. Lee

Research output: Contribution to journalArticle

81 Scopus citations

Abstract

The oxazolidinone antimicrobial linezolid is effective against grampositive bacteria. Although maximal recommended therapy is 28 days, treatment durations greater than this are common. Linezolid may cause reversible optic neuropathy and irreversible peripheral neuropathy after months of treatment. Three cases of linezolid-induced optic and peripheral neuropathy are described, and previously reported cases of linezolid-induced optic neuropathy are reviewed. The mechanism of neural toxicity may be impairment of mitochondrial protein synthesis.

Original languageEnglish (US)
Pages (from-to)595-598
Number of pages4
JournalNeurology
Volume66
Issue number4
DOIs
StatePublished - Feb 2006

Fingerprint Dive into the research topics of 'Linezolid-associated toxic optic neuropathy'. Together they form a unique fingerprint.

  • Cite this

    Rucker, J. C., Hamilton, S. R., Bardenstein, D., Isada, C. M., & Lee, M. S. (2006). Linezolid-associated toxic optic neuropathy. Neurology, 66(4), 595-598. https://doi.org/10.1212/01.wnl.0000201313.24970.b8